Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Role of Leptin in the Neuroendocrine and Immune Response to Fasting

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2012 by Beth Israel Deaconess Medical Center.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Center for Research Resources (NCRR)
Amgen
Information provided by (Responsible Party):
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT00140231
First received: August 30, 2005
Last updated: January 19, 2012
Last verified: January 2012